Reports for APOTEX INC

Company Name

APOTEX INC

Totals

Shortage reports

1799

Actual shortage: 176 (10%)
Anticipated shortage: 4 (0%)
Avoided shortage: 7 (0%)
Resolved: 1612 (90%)

Discontinuation Reports

343

To be discontinued: 21 (6%)
Discontinued: 322 (94%)
Reversed: 0 (0%)

Late reports

120 (6%)

Overdue reports

22 (11%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-05 2021-02-16 133382
APO-GLICLAZIDE MR 60MG TABLET (EXTENDED-RELEASE) Resolved 2021-02-19 2021-03-15 134433
APO-METOPROLOL SR 100MG TABLET (EXTENDED-RELEASE) Actual shortage 2021-04-05 2021-05-03 136802
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-09 2021-05-01 137261
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2021-04-09 2021-05-01 137264
APO-METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Actual shortage 2021-04-16 2021-04-21 137581
APO-DESVENLAFAXINE 50MG TABLET (EXTENDED-RELEASE) Actual shortage 2021-04-30 2021-04-30 138340
APO-METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Actual shortage 2021-05-07 2021-05-07 138960
APO-METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Actual shortage 2021-05-07 2021-05-07 138963
APO-ZOLPIDEM ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-10 2017-04-10 245
APO-ZOLPIDEM ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-10 2017-04-17 249
APO-RIZATRIPTAN RPD 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-11 2020-07-06 490
APO-RIZATRIPTAN RPD 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-11 2018-09-11 493
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-06-13 2017-07-31 12689
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-08-08 2017-08-23 18546
APO-OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-10-03 2018-01-29 24277
APO-ZOLMITRIPTAN RAPID 2.5MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-10-12 2018-09-12 25649
APO-OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-11-13 2018-08-15 29036
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-11-15 2018-01-31 29348
APO-OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2018-04-02 2018-09-04 44507

Showing 1761 to 1780 of 1799

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
APO-DOXY CAP 100MG 100MG CAPSULE Discontinued 2018-09-07 2018-09-29 60459
APO-LITHIUM CARBONATE 300MG CAPSULE Discontinued 2018-09-07 2018-09-15 60588
APO-MYCOPHENOLATE 250MG CAPSULE Discontinued 2018-09-07 2018-09-15 60637
APO-QUININE 200MG CAPSULE To be discontinued 2018-09-08 2018-09-08 60711
APO-QUININE 300MG CAPSULE To be discontinued 2018-09-08 2018-09-08 60714
APO-RAMIPRIL 1.25MG CAPSULE Discontinued 2018-09-08 2019-03-29 60720
APO-SERTRALINE 100MG CAPSULE Discontinued 2018-09-08 2018-09-15 60781
IBUPROFEN LIQUID GEL CAPSULES 200MG CAPSULE Discontinued 2019-01-03 2019-01-03 71095
APO-CLINDAMYCIN 150MG CAPSULE Discontinued 2019-11-11 2019-11-11 98363
APO-DILTIAZ CD 300MG CAPSULE (CONTROLLED-DELIVERY) Discontinued 2019-02-01 2019-02-02 74366
APO-DILTIAZ TZ 120MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1064
APO-DILTIAZ TZ 180MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1069
APO-DILTIAZ TZ 240MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1072
APO-DILTIAZ TZ 300MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1075
APO-DILTIAZ TZ 360MG CAPSULE (EXTENDED RELEASE) Discontinued 2017-03-13 2017-03-13 1078
APO-HYDROMORPHONE CR 3MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110956
APO-HYDROMORPHONE CR 6MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110959
APO-HYDROMORPHONE CR 12MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110962
APO-HYDROMORPHONE CR 18MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110965
APO-HYDROMORPHONE CR 24MG CAPSULE (EXTENDED RELEASE) Discontinued 2020-04-04 2020-04-04 110968

Showing 61 to 80 of 343